Ahsan Akram (MBChB, PhD)
- Cancer Research UK Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine
- MRC Centre for Inflammation Research, QMRI
Contact details
- Tel: 0131 2429100
- Email: ahsan.akram@ed.ac.uk
Address
- Street
-
Cancer Research UK Edinburgh Centre
MRC Institute of Genetics and Molecular Medicine
The University of Edinburgh
Western General Hospital
Crewe Road
EDINBURGH - City
- Post code
- EH4 2XR
- Street
-
The University of Edinburgh/MRC Centre for Inflammation Research
The Queen's Medical Research Institute
47 Little France Crescent - City
- Edinburgh
- Post code
- EH16 4TJ
Background
Ahsan Akram is a Cancer Research UK Clinician Scientist Fellow and Honorary Consultant in Respiratory Medicine. He undertook a PhD in Pulmonary Optical Imaging (2012-2015) and now is planning to apply some of these modalities Lung Cancer for treatment stratification.
Qualifications
MBChB, MRCP, PhD
Open to PhD supervision enquiries?
Yes
Current PhD students supervised
Layla Mathieson- OPTIMA PhD Student
Helen Titmarsh (co-supervisor)- OPTIMA PhD Student
Dr Susan Fernandes (co-supervisor)- MRC Clinical Research Tranining Fellow
Research summary
Characterising and imaging the tumour microenvironment, developing translational imaging tools for human in vivo imaging.
Current project grants
Cancer Research UK Clinician Scientist Fellowship. Fibroblast Activation Protein Expressing Cancer Associated Fibroblasts From Lung Cancer As Imaging Biomarkers For Immunotherapy Stratification. 2017-2022, £1.13M
Wellcome Trust Translation Fund Award. Clinical Validation of Optical Molecular Alveoscopy for the Immediate Bed-Side Diagnosis of Pneumonia in the Intensive Care Unit. Co-applicant on proposal, 2017-21, £3.1M.
-
A Layer-Level Multi-Scale Architecture for Lung Cancer Classification with Fluorescence Lifetime Imaging Endomicroscopy
In:
Neural Computing and Applications
Research output: Contribution to Journal › Article (Accepted/In press) -
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
In:
Nature Communications
Research output: Contribution to Journal › Article (Accepted/In press) -
Fibroblast Activation Protein specific optical imaging in Non-Small Cell Lung Cancer
In:
Frontiers in Oncology
Research output: Contribution to Journal › Article (Accepted/In press) -
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
In:
EBioMedicine
Research output: Contribution to Journal › Article (Accepted/In press) -
Full spectrum fluorescence lifetime imaging with 0.5 nm spectral and 50 ps temporal resolution
In:
Nature Communications, vol. 12
DOI: https://doi.org/10.1038/s41467-021-26837-0
Research output: Contribution to Journal › Article (E-pub ahead of print)